Literature DB >> 11441116

Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms.

N W Lukacs1, K K Tekkanat, A Berlin, C M Hogaboam, A Miller, H Evanoff, P Lincoln, H Maassab.   

Abstract

The development of severe childhood asthma may be influenced by several factors including environmental and infectious stimuli. The causal relationship between infectious viral responses, such as respiratory syncytial virus (RSV), and severe asthma during early childhood is unclear. In these studies, the ability for an initial RSV infection to exacerbate and promote a more severe asthmatic-type response was investigated by combining established murine models of disease. We examined the ability of RSV to induce exacerbation of allergic disease over a relatively long period, leading to development of severe airway responses including airway inflammation and hyperreactivity. The preferential production of IL-13 during a primary RSV infection appears to play a critical role for the exacerbation of cockroach allergen-induced disease. The depletion of IL-13 during RSV infections inhibited the exacerbation and acceleration of severe allergen-induced airway hyperreactivity. This was indicated by decreases in airway hyperreactivity and changes in lung chemokine production. These data suggest that the airway responses during asthma can be greatly affected by a previous RSV infection, even when infection occurs before allergen sensitization. Overall, infection of the airways with RSV can induce an IL-13-dependent change in airway function and promotes an environment that contributes to the development of severe allergic asthmatic responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11441116     DOI: 10.4049/jimmunol.167.2.1060

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  Interleukin-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses.

Authors:  Ruihong Zeng; Huixian Zhang; Yan Hai; Yuxiu Cui; Lin Wei; Na Li; Jianxun Liu; Caixia Li; Ying Liu
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

Review 2.  The role of chemokines in virus-associated asthma exacerbations.

Authors:  Lara E Kallal; Nicholas W Lukacs
Journal:  Curr Allergy Asthma Rep       Date:  2008-09       Impact factor: 4.806

3.  Association of IL-13 in respiratory syncytial virus-induced pulmonary disease: still a promising target.

Authors:  Sumanta Mukherjee; Nicholas W Lukacs
Journal:  Expert Rev Anti Infect Ther       Date:  2010-06       Impact factor: 5.091

4.  Genes associated with RSV lower respiratory tract infection and asthma: the application of genetic epidemiological methods to understand causality.

Authors:  Emma K Larkin; Tina V Hartert
Journal:  Future Virol       Date:  2015-07       Impact factor: 1.831

5.  Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus.

Authors:  Nicholas W Lukacs; Martin L Moore; Brian D Rudd; Aaron A Berlin; Robert D Collins; Sandra J Olson; Samuel B Ho; R Stokes Peebles
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

6.  IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease.

Authors:  Sumanta Mukherjee; Dennis M Lindell; Aaron A Berlin; Susan B Morris; Thomas P Shanley; Marc B Hershenson; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2011-05-03       Impact factor: 4.307

7.  Respiratory virus-induced regulation of asthma-like responses in mice depends upon CD8 T cells and interferon-gamma production.

Authors:  Joost J Smit; Louis Boon; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

8.  A key role for CC chemokine receptor 1 in T-cell-mediated respiratory inflammation.

Authors:  Matthew A Schaller; Lara E Kallal; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

9.  Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model.

Authors:  Asunción Mejías; Susana Chávez-Bueno; Ana María Ríos; Jesús Saavedra-Lozano; Mónica Fonseca Aten; Jeanine Hatfield; Payal Kapur; Ana María Gómez; Hasan S Jafri; Octavio Ramilo
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 10.  Bugs and asthma: a different disease?

Authors:  Dawn C Newcomb; R Stokes Peebles
Journal:  Proc Am Thorac Soc       Date:  2009-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.